High-affinity, neutralizing antibodies to SARS-CoV-2 can be made without T follicular helper cells.
High-affinity, neutralizing antibodies to SARS-CoV-2 can be made without T follicular helper cells.
复制标题
DOI:
10.1126/sciimmunol.abl5652
复制
发表时间:
2022-02-04
影响因子:
24.8
通讯作者:
Eisenbarth SC
中科院分区:
文献类型:
--
作者:
Chen JS;Chow RD;Song E;Mao T;Israelow B;Kamath K;Bozekowski J;Haynes WA;Filler RB;Menasche BL;Wei J;Alfajaro MM;Song W;Peng L;Carter L;Weinstein JS;Gowthaman U;Chen S;Craft J;Shon JC;Iwasaki A;Wilen CB;Eisenbarth SC
T follicular helper (Tfh) cells are the conventional drivers of protective, germinal center (GC)-based antiviral antibody responses. However, loss of Tfh cells and GCs has been observed in patients with severe COVID-19. As T cell-B cell interactions and immunoglobulin class switching still occur in these patients, non-canonical pathways of antibody production may be operative during SARS-CoV-2 infection. We found that both Tfh-dependent and -independent antibodies were induced against SARS-CoV-2 infection, SARS-CoV-2 vaccination, and influenza A virus infection. Even though Tfh-independent antibodies to SARS-CoV-2 had evidence of reduced somatic hypermutation, they were still high-affinity, durable, and reactive against diverse spike-derived epitopes and were capable of neutralizing both homologous SARS-CoV-2 and the B.1.351 (beta) variant of concern. Indeed, we found by epitope mapping and BCR sequencing that Tfh cells focused the B cell response and therefore, in the absence of Tfh cells, a more diverse clonal repertoire was maintained. These data support an alternative pathway for the induction of B cell responses during viral infection that enables effective, neutralizing antibody production to complement traditional GC-derived antibodies that might compensate for GCs damaged by viral inflammation. Complementary Tfh cell-dependent and -independent pathways of antibody production mediate neutralizing responses to SARS-CoV-2.
登录
查看更多内容
DOI:
10.1084/jem.20101773
发表时间:
2011-05-09
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Fahey LM;Wilson EB;Elsaesser H;Fistonich CD;McGavern DB;Brooks DG
通讯作者:
Brooks DG
影响因子:
64.5
作者:
Dejnirattisai W;Zhou D;Ginn HM;Duyvesteyn HME;Supasa P;Case JB;Zhao Y;Walter TS;Mentzer AJ;Liu C;Wang B;Paesen GC;Slon-Campos J;López-Camacho C;Kafai NM;Bailey AL;Chen RE;Ying B;Thompson C;Bolton J;Fyfe A;Gupta S;Tan TK;Gilbert-Jaramillo J;James W;Knight M;Carroll MW;Skelly D;Dold C;Peng Y;Levin R;Dong T;Pollard AJ;Knight JC;Klenerman P;Temperton N;Hall DR;Williams MA;Paterson NG;Bertram FKR;Siebert CA;Clare DK;Howe A;Radecke J;Song Y;Townsend AR;Huang KA;Fry EE;Mongkolsapaya J;Diamond MS;Ren J;Stuart DI;Screaton GR
通讯作者:
Screaton GR
影响因子:
64.5
作者:
Hoffmann M;Arora P;Groß R;Seidel A;Hörnich BF;Hahn AS;Krüger N;Graichen L;Hofmann-Winkler H;Kempf A;Winkler MS;Schulz S;Jäck HM;Jahrsdörfer B;Schrezenmeier H;Müller M;Kleger A;Münch J;Pöhlmann S
通讯作者:
Pöhlmann S
影响因子:
4.4
作者:
Junt, T;Fink, K;Hengartner, H
通讯作者:
Hengartner, H
影响因子:
64.8
作者:
Crotty, S;Kersh, EN;Ahmed, R
通讯作者:
Ahmed, R